Work

Supplemental Tables 1-4 from Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Tables 1-4. Table 1: pLKO shRNA clone information and antibody information. Table 2: Combination Indices to assess for synergism. Table 3: Quantitative 1H-, 31P- and 13C-NMR analysis of K562 CML cells treated with vehicle imatinib, oligomycin-A or the combination imatinib + oligomycin-A. Table 4: Complete blood counts and metabolic profiles after in vivo treatment with Oligomycin-A

DOI: 10.1158/1078-0432.22458098

Authors: Francesca Alvarez-Calderon, Mark A. Gregory, Catherine Pham-Danis, Deborah DeRyckere, Brett M. Stevens, Vadym Zaberezhnyy, Amanda A. Hill, Lelisa Gemta, Amit Kumar, Vijay Kumar, Michael F. Wempe, Daniel A. Pollyea, Craig T. Jordan, Natalie J. Serkova, Douglas K. Graham, James DeGregori

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362432674

Cites:

Cited by:

Related to: 10